Tetraphase Pharmaceuticals

Tetraphase Pharmaceuticals

Tetraphase has developed a robust antibiotics platform based on the tetracycline core, which offers the potential to dramatically improve the treatment of both broad and selective spectrum bacterial infections.

< Back to Portfolios